Catherine Friedman - Altaba Insider

AABA -- USA Stock  

USD 79.46  0.16  0.20%

Independent Director

Ms. Catherine J. Friedman is an Independent Director of the Company. Ms. Friedman has served as a member of our Board since March 2016. Ms. Friedman was an independent financial consultant serving public and private companies in the life sciences industry since 2006. Prior to that, Ms. Friedman held numerous positions over a 23year investment banking career with Morgan Stanley, including Managing Director from 1997 to 2006 and Head of West Coast Healthcare and CoHead of the Biotechnology Practice from 1993 to 2006. Ms. Friedman is a member of the boards of directors of GSV Capital Corporationration, a publiclytraded business development company, Innoviva, Inc., a royalty management company specializing in respiratory assets, and Radius Health, Inc., a biopharmaceutical company. She previously served as a member of the boards of directors of EnteroMedics Inc., a medical device company, from May 2007 to May 2016, and Xenoport, Inc., a biopharmaceutical company, from September 2007 until July 2016.
Age: 55  Director Since 2016      
646-679-2000  http://www.altaba.com

Management Efficiency

The company has return on total asset (ROA) of 0.01 % which means that it generated profit of $0.01 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 47.31 % meaning that it created $47.31 on every $100 dollars invested by stockholders.
The company currently holds 1.37 B in liabilities with Debt to Equity (D/E) ratio of 2.1 implying the company greatly relies on financing operations through barroing. Altaba has Current Ratio of 16.73 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Entity Summary

Altaba Inc. operates as a non-diversified, closed-end management investment company in the United States. Altaba Inc. was founded in 1994 and is based in New York, New York. Altaba operates under Asset Management classification in USA and traded on NASDAQ.Altaba (AABA) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 8,800 people. Altaba was previously known as Altaba and was traded on NASDAQ under the symbol YHOO. Altaba is listed under Computers category by Fama And French industry classification.

Altaba Leadership Team

Catherine Friedman, Director
Richard Kauffman, Director
Thomas McInerney, CEO
Alexi Wellman, Executive
Arthur Chong, Executive
Tor Braham, Director
DeAnn Work, Executive
Eric Brandt, Chairman

Stock Performance Indicators

Current Sentiment - AABA

Altaba Investor Sentiment
Most of Macroaxis users are presently bullish on Altaba. What is your sentiment towards investing in Altaba? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Altaba and Digimarc. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.